Taking a Closer Look At Sarepta Therapeutics Inc (SRPT) Following Its Recent Trade

Sarepta Therapeutics Inc’s filing revealed that its Director Nicaise Claude unloaded Company’s shares for reported $0.25 million on Mar 12 ’25. In the deal valued at $99.64 per share,2,491 shares were sold. As a result of this transaction, Nicaise Claude now holds 27,812 shares worth roughly $0.53 million.

Then, Nicaise Claude bought 2,491 shares, generating $248,226 in total proceeds.

Before that, Wigzell Hans Lennart Rudolf sold 10,500 shares. Sarepta Therapeutics Inc shares valued at $1,310,820 were divested by the Director at a price of $124.84 per share. As a result of the transaction, Wigzell Hans Lennart Rudolf now holds 22,840 shares, worth roughly $0.43 million.

William Blair downgraded its Sarepta Therapeutics Inc [SRPT] rating to a Mkt perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including TD Cowen’s analysts, who decreased its forecast for the stock in mid June from “a Buy” to “a Hold”. Wolfe Research began covering SRPT with “Peer perform” recommendation on June 17, 2025. Piper Sandler revised its rating on June 16, 2025. It rated SRPT as “a Neutral” which previously was an “an Overweight”.

Price Performance Review of SRPT

On Tuesday, Sarepta Therapeutics Inc [NASDAQ:SRPT] saw its stock jump 9.87% to $19.03. Over the last five days, the stock has gained 11.29%. Sarepta Therapeutics Inc shares have fallen nearly -87.57% since the year began. Nevertheless, the stocks have fallen -84.35% over the past one year. While a 52-week high of $154.90 was reached on 01/07/25, a 52-week low of $16.88 was recorded on 07/01/25.

Levels Of Support And Resistance For SRPT Stock

The 24-hour chart illustrates a support level at 17.80, which if violated will result in even more drops to 16.57. On the upside, there is a resistance level at 19.81. A further resistance level may holdings at 20.59.

How much short interest is there in Sarepta Therapeutics Inc?

A steep rise in short interest was recorded in Sarepta Therapeutics Inc stocks on 2025-06-13, growing by 1.06 million shares to a total of 9.89 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 8.83 million shares. There was a rise of 10.72%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.